RAIN THERAPEUTICS INC's ticker is RAIN and the CUSIP is 75082Q105. A total of 50 filers reported holding RAIN THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $11,703,001 | +14.3% | 1,336,722 | +4.1% | 0.01% | +14.3% |
| Q4 2022 | $10,242,378 | +162.6% | 1,283,506 | -20.7% | 0.01% | +133.3% |
| Q3 2022 | $3,899,896 | -4.4% | 1,618,208 | +120.9% | 0.00% | 0.0% |
| Q2 2022 | $4,080,000 | +26.6% | 732,655 | +15.1% | 0.00% | +50.0% |
| Q1 2022 | $3,223,000 | -79.7% | 636,768 | -48.2% | 0.00% | -71.4% |
| Q4 2021 | $15,841,000 | -22.6% | 1,230,455 | -12.2% | 0.01% | -22.2% |
| Q3 2021 | $20,455,000 | -4.8% | 1,402,074 | -3.5% | 0.01% | 0.0% |
| Q2 2021 | $21,491,000 | – | 1,452,615 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,637,308 | $25,444,000 | 3.14% |
| Cormorant Asset Management, LP | 2,626,660 | $39,734,000 | 1.35% |
| BVF INC/IL | 1,945,949 | $30,240,000 | 1.13% |
| Logos Global Management LP | 780,331 | $12,126,000 | 1.02% |
| ACUTA CAPITAL PARTNERS, LLC | 162,245 | $2,521,000 | 1.01% |
| LUMINUS MANAGEMENT LLC | 425,000 | $6,605,000 | 0.96% |
| Boxer Capital, LLC | 1,175,000 | $18,260,000 | 0.64% |
| Perceptive Advisors | 5,074,038 | $78,850,000 | 0.51% |
| Lumina Fund Management LLC | 6,000 | $93,000 | 0.04% |
| Monashee Investment Management LLC | 20,000 | $311,000 | 0.04% |